Target intelligence / Profile preview

Internalin A (InlA) (InlA)

Target
InlA
Molecular classification
Surface protein, Adhesin, Leucine-rich repeat (LRR) protein
01

Overview

Internalin A (InlA) is a critical surface protein of the Gram-positive bacterium Listeria monocytogenes, belonging to the internalin family characterized by leucine-rich repeat (LRR) domains. It serves as a primary ligand that mediates the attachment and entry of the pathogen into host epithelial cells by binding specifically to the host cell surface receptor E-cadherin. This interaction is essential for the bacterium to cross major physiological barriers, including the intestinal and placental barriers, which leads to systemic listeriosis. While not a target for conventional antibiotics, InlA is a significant focus for the development of novel anti-infective strategies, such as monoclonal antibodies and vaccines designed to block bacterial internalization. Understanding the structure and function of InlA and its counterparts, like Internalin B (InlB), is essential for developing targeted interventions against Listeria-mediated infections.

Other names
InlALmo0433Internalin-AListeria monocytogenes surface proteinListeria monocytogenes surface receptor
02

Mechanism of action

Inhibition of bacterial adhesion and internalization into host cells by blocking the interaction between InlA and host E-cadherin.

03

Biological functions

Host cell invasionAdhesionBinding to E-cadherinCrossing physiological barriers
04

Disease associations

InfectionListeriosis
05

Safety considerations

Immune response to the bacteriumPotential for off-target effects if targeting host receptorsBacterial resistance mechanisms
06

Biomarkers

Listeria monocytogenes detectionInlA expression

Beyond the preview

Go deeper on Internalin A (InlA) (InlA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Internalin A (InlA) (InlA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call